Log In
Print
BCIQ
Print
Print this Print this
 

VEDA-1209

  Manage Alerts
Collapse Summary General Information
Company Cureveda LLC
DescriptionSmall molecule activator of nuclear factor (erythroid-derived 2)-like 2 (NFE2L2; NRF2)
Molecular Target Nuclear factor (erythroid-derived 2)-like 2 (NFE2L2) (NRF2)
Mechanism of ActionNuclear factor (erythroid-derived 2)-like 2 (NFE2L2) (NRF2) activator
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationInflammatory bowel disease (IBD)
Indication DetailsTreat ulcerative colitis (UC)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today